SecBot SecBot
PRESS-RELEASE ·Filed Nov 5, 2026

INO

Inovio Pharmaceuticals, Inc.
BEARISH
Impact 4/10
Horizondays Processed11d 10h ago WireGlobeNewswire
Press release · Offering
Actionable Insight ▼ Bearish

Monitor the preliminary prospectus supplement for offering size and pricing. The company's high volatility (23% normal daily move) means even a moderate-sized offering could have outsized price impact. Watch for any subsequent updates on use of proceeds or financial runway.

DirectionBearish
Confidencemedium
Horizondays

How the stock moved after the report

⚠ Clustered BEARISH VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$1.22
T+0 close · Nov 5, 2026 · via day close
Latest settled
+17.70%
T+5 · $1.43 · next T+20 in 20d
Vs SPY
+15.10%
α at T+5
Latest observation
+17.93%
T+6 · FF3 residual α
  1. T+0 · Nov 6 $1.22entry
  2. T+1 · 8d ago +24.28%α +21.91% · $1.51
  3. T+5 · 4d ago +17.70%α +15.10% · $1.43
  4. T+6 · todayOpen
  5. T+20 · in 20d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Inovio Pharmaceuticals announced an underwritten public offering of common stock with a 30-day underwriter option for up to 15% additional shares. The offering size and pricing are undisclosed; proceeds will be used for general corporate purposes. This dilutive event comes at a market cap of $172M and high volatility (23% normal daily move).

Key Facts

  • Inovio intends to offer shares of common stock in an underwritten public offering
  • Underwriters granted a 30-day option to purchase up to 15% additional shares
  • Jefferies and Piper Sandler are joint book-running managers
  • Offering is subject to market conditions; size and terms not disclosed
  • Shelf registration statement filed July 2, 2026 and declared effective July 10, 2026

Financial Impact

Undisclosed amount; market cap is $172M, so any material offering will be dilutive relative to current shares outstanding

dilutionshare count

Risk Factors

  • Offering size and pricing are undisclosed, creating uncertainty about dilution magnitude
  • High stock volatility (23% normal daily move) amplifies price sensitivity to offering terms
  • Market conditions may prevent completion of the offering on favorable terms

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
71% bullish (7 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-prn-302931327

Track record

20 reports on INO

Performance horizon

8 of 13 bullish or bearish reports moved the stock their way by T+5. Best: +46.23% at T+20 after the Jul 2, 2026 report. 9 of 14 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 4/10 Entry $1.39 Now $1.40 +0.72% settles Nov 24
  2. Nov 16, 2026today SC 13G/A Bearish 4/10 Entry $1.40 Now $1.40 −0.01% settles Nov 24
  3. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $1.41 Now $1.40 −0.71% settles Nov 23
  4. Nov 10, 20266d ago 8-K Bearish 5/10 Entry $1.48 Now $1.40 +5.08% settles Nov 18
  5. Nov 9, 20267d ago 8-K Bearish 5/10 Entry $1.51 to $1.40 Now $1.40 +7.28% ▲ +7.28% +5.59% vs SPY
  6. Nov 6, 202610d ago 424B5 Bearish 5/10 Entry $1.51 to $1.40 Now $1.40 +7.28% ▲ +7.28% +5.59% vs SPY
  7. Nov 5, 202611d ago Press Release Bearish 6/10 Entry $1.22 to $1.43 Now $1.40 −15.23% ▼ −17.70% −15.10% vs SPY
  8. Nov 5, 202611d ago 8-K Bearish 5/10 Entry $1.22 to $1.43 Now $1.40 −15.23% ▼ −17.70% −15.10% vs SPY
  9. Nov 5, 202611d ago 424B5 Bearish 4/10 Entry $1.22 to $1.43 Now $1.40 −15.23% ▼ −17.70% −15.10% vs SPY
  10. Nov 5, 202611d ago Press Release Bearish 4/10 Viewing Entry $1.22 to $1.43 Now $1.40 −15.23% ▼ −17.70% −15.10% vs SPY
Showing 10 of 20

US Market Status

Market Closed · Opens in 6h 33m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 5, 2026